were dramatically stained red and easy to identify. This was also true for the demonstration of intracytoplasmic protein droplets in other organs.
However, fibrinoid showed different tinctorial properties in various diseases as mixtures of red and blue staining. There were correlations with the age and intensity of the disease process. Differences also were confirmed using fluorescent antibodies to human plasma proteins and electron microscopy. I completely agree with the authors on the utility of the Chromotrope 2R-aniline blue method in demonstrating renal protein droplets in tubular epithelial cells. However, the use of Alcian blue in place of aniline blue at pH 2.0-2.2, converts a special stain into a histochemical procedure which sets the stage for further exploration of pathogenesis. My papers appeared in 1955 and 1957, the Neolithic period, compared to molecular biology. Nevertheless, archeologists are always amazed at the inventiveness and skills of old civilizations. I hope the authors will continue to mine the histochemical literature for additional methods in the elucidation of disease pathogenesis.
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